TIDMAMS

RNS Number : 3859E

Advanced Medical Solutions Grp PLC

09 February 2018

 
   9 February 2018

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Notice of Preliminary Results

Winsford, UK, 9 February 2018: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, will announce its preliminary results for the year ended 31 December 2017 on Wednesday 14 March 2018.

A briefing for analysts will be held at 9.30am GMT on the day of results in the Guildhall Room at 85 Gresham Street, London EC2V 7NQ. Please contact Consilium Strategic Communications for further details.

-End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                       Tel: +44 (0) 
  plc                                                    1606 545508 
 Chris Meredith, Chief Executive 
 Officer 
 Mary Tavener, Group Finance Director 
 
 Consilium Strategic Communications                     Tel: +44 (0) 
                                                        20 3709 5700 
 Mary-Jane Elliott / Matthew Neal            AMS@consilium-comms.com 
  / Philippa Gardner/ Rosie Phillips 
 
 Investec Bank PLC (NOMAD & Broker)                     Tel: +44 (0) 
                                                        20 7597 5970 
 Daniel Adams / Gary Clarence 
  / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORGMGGZRRMGRZM

(END) Dow Jones Newswires

February 09, 2018 02:00 ET (07:00 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.